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Abstract
Background: Can the application of local anesthetics (Neural Therapy, NT) alone durably improve pain symptoms
in referred patients with chronic and refractory pain?
If the application of local anesthetics does lead to an improvement that far exceeds the duration of action of local
anesthetics, we will postulate that a vicious circle of pain in the reflex arcs has been disrupted (hypothesis).
Methods: Case series design. We exclusively used procaine or lidocaine. The inclusion criteria were severe pain and
chronic duration of more than three months, pain unresponsive to conventional medical measures, written referral
from physicians or doctors of chiropractic explicitly to NT. Patients with improvement of pain who started on additional
therapy during the study period for a reason other than pain were excluded in order to avoid a potential bias.
Treatment success was measured after one year follow-up using the outcome measures of pain and analgesics intake.
Results: 280 chronic pain patients were included; the most common reason for referral was back pain. The average
number of consultations per patient was 9.2 in the first year (median 8.0). After one year, in 60 patients pain was
unchanged, 52 patients reported a slight improvement, 126 were considerably better, and 41 pain-free. At the
same time, 74.1 % of the patients who took analgesics before starting NT needed less or no more analgesics at
all. No adverse effects or complications were observed.
Conclusions: The good long-term results of the targeted therapeutic local anesthesia (NT) in the most problematic
group of chronic pain patients (unresponsive to all evidence based conventional treatment options) indicate that
a vicious circle has been broken. The specific contribution of the intervention to these results cannot be determined.
The low costs of local anesthetics, the small number of consultations needed, the reduced intake of analgesics, and the
lack of adverse effects also suggest the practicality and cost-effectiveness of this kind of treatment. Controlled trials to
evaluate the true effect of NT are needed.
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Background
Background and objective
The number of chronic pain syndromes is rapidly increas-
ing [1, 2]. Moreover, chronic pain has an enormous socio-
economic impact [3]. The hopes that have in the past
years been placed on efficient medical drug therapies
causing very few side effects have been disappointed in
parts. This is why non-medical treatment options have
been sought after, too. A logical option to consider is the
regulating therapy using local anesthetics (Neural Ther-
apy, NT), which is based on both experience [4, 5] and the
findings of modern pain physiology [6, 7]. A national
cross-sectional survey that was conducted among 300
randomly selected primary care physicians in Germany at-
tests to the great importance of NT in terms of application
frequency and subjective perception of efficacy [8].
The present case series was undertaken to answer the
question if the application of NT alone (i.e., without using
any additional measures) can produce long-term improve-
ment of the pain symptoms in referred patients with
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chronic and so far refractory pain. A case series design
was used to investigate the level of pain relief, the
consumption of pain medication as well as safety issues.
At the same time, we tested the following hypothesis,
postulated on the basis of the interpretation of findings
from modern neurophysiology of pain: A vicious circle
in the pain process can be disrupted by injecting local
anesthetics into suitable sites of the body, which is
reflected by the fact that the effect lasted much longer
than could be expected from the duration of action of
the local anesthetic. At the same time, we accept that
specific and non-specific effects of treatment cannot be
clearly discriminated.
Definition of neural therapy
NT is a treatment modality using injections with local
anesthetics for diagnosis and therapy (indications in-
clude functional disorders, inflammatory diseases and
acute and chronic pain). The real purpose, though, is
not to achieve local anesthesia (except for diagnosis).
The generation of targeted stimuli (through the needle)
and the selective extinction of other stimuli (through
the local anesthetic) affect both the organization of the
nervous system and tissue perfusion, thereby disrupting
positive feedback actions (vicious circle) in the pain
cycle. This treatment modality utilizes the regulatory
mechanisms and plastic properties of the nervous
system, mainly on two levels: first, via segmental reflec-
tory processes [9–11], and second, via the so called
interference field (irritation zone), which may initiate
and/or maintain pain and inflammation, regardless of
the involved segment [4, 5, 9–16]. The neurophysio-
logical rationale and the mechanisms of action will be
outlined in the discussion section.
Methods
Design
A case series design was used including patients from a
University practice specializing in NT (Professor of
Neural Therapy, University of Bern). All patients that
met the inclusion criteria and had been referred expli-
citly to NT between January 1, 2000 and December 31,
2007, were included in the retrospective analysis. Each
patient was followed over a period of 12 months. The
local ethics committee concluded that no special ap-
proval was needed for the following reasons, and there-
fore, granted permission for us to access patients’ data
for the purposes of our study: Not only the referral
explicitly to NT, but the treatment, too, was completely
independent from the retrospective analysis; written
informed consent was obtained from all patients; and
the application of an accepted treatment was by defin-
ition in full compliance with the statements in the
Helsinki Declaration. Therefore, the study passed the
review process at the University of Bern to be accepted
as doctoral thesis.
Patients
Inclusion criteria
– Patients with pain and written referral explicitly to
NT from physicians or doctors of chiropractic
– Chronic condition lasting more than 3 months
– Treatment-resistant pain, i.e., pain persisting after all
other evidence-based (conventional medical) mea-
sures compatible with the diagnosis (especially pain
medication) have failed.
– Only patients were included whose pain was at least
severe,1 regardless of their pain medication
(example: If pain medication had reduced a patient’s
pain from very severe to mild levels at recruitment,
this patient was excluded since his pain was neither
treatment-resistant nor was there any drug
intolerance).
Exclusion criteria / drop-out
– Conventional medical treatment options (in
accordance with the diagnosis) have not been fully
exhausted at the beginning of NT.
– To avoid a potential bias, patients with
improvement of pain who started on another
therapy during the one-year treatment period for a
reason other than pain but with the potential to in-
fluence the pain level in a positive way (e.g. rigorous
diet, psychotherapy, etc.) were excluded from the
analysis.
– Discontinuation of NT due to accident, new onset
of a serious disease, moving house, etc.
Intervention
Exclusive diagnostic and therapeutic application of the
local anesthetics procaine or lidocaine in terms of NT
(see definition).
Data acquisition
During the first consultation data were collected on
age, sex, duration of pain problem, diagnosis, severity
of pain, secondary diagnoses, and both the outcomes of
previous therapies and the medication documented. For
each individual consultation, interventions with local anes-
thetics, change in pain, medication use, adverse effects
and complications were recorded over a 12-month study
period. At the final visit (12 months after starting NT) the
patients were asked to indicate their current level of pain,
and both the number of consultations during the past
12 months and the current medication was documented.
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In order to grade the severity of pain (see inclusion
criteria) and examine the change in pain a deliberate
choice was made to forego the use of a visual analog
scale in favor of MacNab’s criteria, which for the
purpose of the present case series seemed to be more
appropriate (modified according to Schmid [17]). Re-
garding the change in pain after one year the results
were as follows: I: no pain, II: considerable improve-
ment (more than 50 %), III: slight improvement (less
than 50 % of the initial pain at the end of the follow-up
period), IV: no change, V: worsening. Additionally, pa-
tients were not only asked to selectively rate their pain
level, but also the average monthly pain level in the
month before beginning NT and in the twelfth month.
Again, the simple MacNab criteria appeared to us to be
more practical than the visual analog scale.
Patients with a fluctuating course who reported im-
provements with NT, but rated their level of pain after
one year as being no different from the pain intensity
before the beginning of NT, were assigned to the “no
improvement” category. In the case of patients with
multiple pain problems only the primary diagnosis
(cause of referral) was evaluated.
For purposes of documenting the medication use after
treatment with NT (after one year) the following categor-
ies were used: 1. more medication than before starting
treatment, 2. less medication, 3. no change in medication
intake, 4. no medication taken before and after treatment.
Only pain-relieving and pain-modulating drugs were
considered.
The case series did not include patients who had not
fully exhausted either conventional medical treatments
previously or had not been resistant to treatment before
beginning NT. Patients were not excluded, though, if
NT was prematurely discontinued due to lack of success,
but were assigned to the “no improvement” category
(two patients).
The diagnoses were recorded according to the ICD-10
Code and then subdivided into four large pain-related
diagnostic groups: 1. disorders of the spine and back, 2.
disorders of other parts of the motor system, 3. head-
aches, 4. other pains.
The outcome of NT interventions were summarized in
a report and communicated to the referring physician.
Statistical procedures
Fisher’s exact test was used to statistically identify
differences in the frequency between groups. With con-
tinuous and discrete data (age, number of treatments,
etc.), the Wilcoxon or the Kruskal-Wallis test was used
to determine the magnitude of difference between groups.
Monotonic associations between some of the variables were
identified using Spearman’s rank correlation coefficient. A
p value of <0.05 was used to denote statistical significance.
Results
Demographic data and the Patients’ general state of health
In the above-mentioned period a total of 361 chronic
pain patients had a written referral for NT. 59 patients
were not included since their pain levels did not exceed
categories 1–3 (see inclusion criteria). Seven patients
could not be enrolled in the case series because they had
started another treatment simultaneously with the be-
ginning of NT. To avoid another potential bias, eleven
patients with improvement of pain were later excluded
because they began another treatment for a reason other
than pain during the one-year study period, potentially
influencing the pain level in a positive way (e.g. rigorous
diet, psychotherapy, etc.). Another four patients were
excluded because of external factors (accident, moving
home, etc.).
Finally, 280 patients were included in the case series. All
patients suffered from chronic pain which had so far been
treated with no success and may thus be regarded as unre-
sponsive to treatment. All conventional treatment options
had been fully exhausted in accordance with the respective
diagnosis. All patients had previously received medical
treatment; in 31 % of the patients the pharmacologic
treatment approach of pain had been stopped before start-
ing NT, one reason being a lack of effect, another the
occurrence of adverse effects. More than two thirds of the
patients had previously undergone physical therapy,
physiotherapy, osteopathy or chirotherapy, and 25 % of
the patients had also tried acupuncture. All pain condi-
tions were resistant to these procedures as well.
176 women and 104 men were included; the average age
of the females was 50.1 years (SD: 15.1; range: 14–84) and
of the males 50.9 years (SD: 14.4; range: 11–90) (Table 1).
Specialties of referring physicians
All patients were referred by physicians from a broad
spectrum of professional disciplines (Table 2). 36 of the
patients had referrals from various specialist clinics of a
university hospital.
Symptoms and diagnoses
More than two thirds of the patients (69.6 %) suffered
from treatment-resistant pain disorders of the spine and
of other parts of the motor system. Every eighth patient
(12.2 %) complained of headache (Table 3).
Table 1 Distribution by age and sex
Sex n Age (years)
Mean (SD) Median Range
Female 176 50.1 (15.1) 51 14–84
Male 104 50.9 (14.4) 51 11–90
Total 280 50.4 (14.9) 51 11–90
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Duration of illness
The mean duration of illness in all patients before start-
ing NT was 64 months, i.e., more than five years. The
distribution of duration of illness was skewed, meaning
that 50 % of all patients had been ill for less than
36 months and 4 patients for more than 360 months.
Table 4 shows the mean (incl. SD) and median duration
of illness of the four most important diagnostic groups.
There was a statistically confirmed difference in the dur-
ation of illness between these four diagnostic groups
(p = 0.04), in that patients afflicted with headache and
facial pain showed a longer duration of illness before
their referral than the other three groups (Table 4). An
analysis of the duration of illness in relation to five age
categories (0–20, 21–40, 41–60, 61–80, >80 years of age)
did not reveal any significant differences between the
age groups (p = 0.14). Also, there was no difference
between female and male patients (p = 0.41).
Number of treatments
The number of treatment sessions utilized by patients
in the first year varied between one and 40, the average
number being 9.16 (SD: 5.69), and the median number
8.0. There was a statistically confirmed difference in
the number of treatments between diagnostic groups
(p = 0.01). In the first year, patients suffering from
painful musculoskeletal disorders affecting the spine
and back needed more consultations than the other
three groups (Table 5). There were no significant differ-
ences in the number of consultations in relation to age
groups (p = 0.11), but female patients required signifi-
cantly more (i.e., 10.6) consultations (p < 0.01) than
male patients (7.6 consultations).
Correlation coefficients between age, duration of illness
and number of consultations and their corresponding
p values are listed in Table 6. The correlation coefficients
Table 2 Distribution of referring doctors
Referring physicians by specialty Frequency of referral
General Medicine 147
Chiropractic 38
Internal Medicine 30
Rheumatology 16
Orthopedic Surgery 10
Otorhinolaryngology 8
Ophthalmology 8
Hand Surgery 5
Pediatrics 4
General Surgery 3
Anesthesia (Pain Clinics) 2
Gynecology 2
Psychiatry 2
Urology 2
Neurology 1
Insurance Medicine (casualty insurer SUVAa) 1
Dentistry 1
Various physicians referred several patients. The 5 physicians who most
frequently referred patients with treatment-resistant pain sent the following
number of patients during the enrollment period: 27, 21, 15, 13 and
8, respectively
a SUVA (Swiss National Accident Insurance Fund) is the largest provider of
accident insurance in Switzerland
Table 3 Diagnosis codes
Diagnosis (ICD 10) Frequency %
1. Disorders of the spine and back 155 55.3
2. Other disorders of the motor system
Arthropathies 18 6.4
Soft tissue disorders 16 5.7
Osteopathies 4 1.4
Chondropathies 2 0.7
Systemic connective tissue disorders 1 0.4
Total 41 14.6
3. Headaches
Atypical facial pain 13 4.7
Chronic post-traumatic headache 5 1.8
Cluster headache 5 1.8
Other headaches 5 1.8
Migraine 4 1.4
Trigeminal neuralgia 2 0.7
Total 34 12.2
4. Other pain
Diseases of the eye 7 2.5
Diseases of the genitourinary system, male 5 1.8
Diseases of the genitourinary system, female 3 1.1
Diseases of the digestive system 3 1.1
Other diseases 32 11.4
Total 50 17.9
All groups 280 100
Table 4 Duration of Illness before the beginning of neural
therapy (in months)
Diagnosis code Patients (n) Duration of illness
(months)
Mean (SD) Median
Disorders of the spine and back 155 64.65 (91.59) 36
Other disorders of the motor system 41 43.98 (55.75) 24
Headache 34 106.50 (130.30) 54
Other pain 50 49.50 (53.54) 24
Total 280 64.00 (88.91) 36
Egli et al. BMC Complementary and Alternative Medicine  (2015) 15:200 Page 4 of 9
reveal a weak and non-significant linear association be-
tween age and duration of illness and a weak, but signifi-
cant association between the age and the number of
consultations.
Change in pain
Treatment success from the patients’ perspective is
shown in Table 7. One patient felt that his pain had
worsened, and 60 patients reported that their symptoms
were unchanged. Rating the success of their treatment
after one year, 52 patients saw a slight and 126 patients
a considerable improvement. 41 patients were pain-free
after one year. Treatment success was not significantly
different between the diagnostic groups (p = 0.14).
157 patients (56 %) underwent local/segmental ther-
apy, 5 patients (2 %) received interference field therapy,
and 118 patients (42 %) a combined (local/segmental
plus interference field) treatment (Table 8). A compari-
son of change of pain between a purely local/segmental
and a combined therapy did not reveal any statistically
confirmed difference (p value Fisher test = 0.28). Due to
the small number of patients, interference field therapy
alone was not included in the statistical calculations
(Table 8).
Consumption of pain medication
Table 9 displays the consumption of pain medication
after one year as compared to the consumption before
NT, separately listed for the group of patients with suc-
cessful NT (n = 219; slight improvement to freedom
from symptoms) and for the group of patients with no
treatment success (n = 61; no change or worsening). Suc-
cessfully treated patients needed significantly less pain
medication (p < 0.01).
Eighty-seven patients did not take any pain medica-
tion, neither when they were included nor after they
started NT. However, these patients had – at some earl-
ier point during the course of their disease – also re-
ceived one or more pain-relieving drugs prior to NT, but
had discontinued their medication because of lack of ef-
fect or intolerable adverse effects. After one year none of
these patients used any pain medications.
In 50 patients (25.9 % of the patients taking pain re-
lievers at the beginning of NT) pain medication con-
sumption was unchanged, and 143 patients (74.1 %)
used less or no more pain medication at all after the
period under study.
Observation of adverse effects or complications
No adverse effects or complications occurred except
minor, spontaneously resolving hematoma and mild diz-
ziness lasting up to 15 min following treatment, which
in patients with normal blood pressure was assessed as
the known systemic procaine effect and simultaneous,
mild vasovagal reaction. There was no case where an ad-
verse effect would have required drug treatment or any
other intervention.
Discussion
Neurophysiology and mechanisms of action
Nociceptive processes cause a reflex response evoked by
cutivisceral, viscero-cutaneous, viscero-somatic motor,
etc. reflex pathways. This reflex response, which is
largely mediated by sympathetic nerves, involves changes
in blood flow, increased skin turgor, hyperalgesia in lo-
calized areas of skin, dysregulation of the organ at the
corresponding metameric level, as well as increased
muscle tone [18–20]. Nociceptive afferents converge in
the dorsal horn of the spinal cord. The information from
this area is then diverged: to the sympathetic nervous
system, to the skeletal muscles, and to the brain, all at
the same time (Fig. 1) [6, 7, 21].
Analogous to mathematical chaos theory these con-
nections create a vicious circle (positive feedback, iter-
ation) of pain [20]. This vicious circle is reinforced
because under pathological conditions efferent (!) sym-
pathetic nerves in the periphery are able to relay to noci-
ceptive afferents in a kind of short circuit, leading to a
coupling between sympathetic and afferent neurons [7,
22–24]. Sympathetic-afferent coupling and also neuro-
plastic changes [25] within the spinal cord and in the
brain produce additional multiple iterations of the vi-
cious circle of pain.
The sympathetic nervous system can induce a neuro-
genic inflammation via vasodilation and plasma extravasa-
tion and the release of pro-inflammatory neuropeptides
from its own nerve fibers [26–31]. This inflammation
decreases the response threshold of nociceptors and
Table 5 Number of treatments in the first year
Diagnosis code Patients (n) Treatments
Mean (SD) Median
Disorders of the spine and back 155 10.00 (5.97) 8.00
Other disorders of the motor system 41 7.07 (4.95) 5.00
Headache 34 8.44 (5.12) 8.50
Other pain 50 8.78 (5.31) 9.00
Total 280 9.16 (5.69) 8.00
Table 6 Correlation coefficients between age, duration of illness
and number of consultations
Age Duration of illness
correlation
coefficient
p value * correlation
coefficient
p value
Duration of
illness
0.11 0.06
Consultations 0.14 0.01 0.06 0.28
* p value, i.e., the statistical test for a correlation coefficient ≠ 0
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simultaneously recruits quiescent or “silent” nociceptors
from the neighborhood. Thus peripheral sensitization oc-
curs [22], which reinforces the vicious circle even further.
Tracey [32] describes an “inflammatory reflex of the
autonomic nervous system,” reflexively adjusting the in-
flammatory and immune responses of the human body.
As early as 1924 Ricker [33] was able to demonstrate
in an animal model that even injuries to the sympathetic
nervous system or pathological irritations which oc-
curred a long time ago would become engrammatically
stored. Every new (physiological) stimulus to such a sys-
tem causes a pathological (excessive) response. It seems
that the sympathetic nervous system has a kind of
“memory” for pathological stimuli.
Using local anesthetics (NT) these different levels can
be accessed directly and logically: by applying an impulse
(needle prick) and by disrupting a vicious circle (local
anesthetic). Repeated application can lead to the “extinc-
tion” of the engrammatically stored pathological irritabil-
ity of the sympathetic nervous system and to the
restoration of normal tissue perfusion [9, 20, 34]. The
local anesthetic can disrupt the escalating vicious circle
of nociceptor activity – sympathetic excitation – circula-
tion disturbance – neurogenic inflammation – muscle
hardening, etc. in different sites at the same time
(Figure 1). In this way several interrelated and, through
positive feedback loops, ever-increasing reflex arcs become
disrupted.
Moreover, Cassuto [26] was able to show that repeated
application of local anesthetics can also directly reduce
neurogenic inflammation.
In addition, needle prick and local anesthetic can pro-
duce a favorable effect on the control of synaptic input
to the neurons in the dorsal horn of the spinal cord [35].
Interpretation of data
Reflecting the real-life setting of our University NT prac-
tice, our case series included the most difficult category of
patients with chronic pain, i.e. chronic pain unresponsive
to all evidence-based, conventional medical measures and
various complementary treatments over a long period,
who had been referred explicitly to NT. For these reasons
randomization of a part of these patients in a control
group without NT was not possible. Upon closer consider-
ation, the fact that all previous therapies had failed can
serve as a kind of comparison (albeit with some time lag)
between conventional (incl. complementary) medical
treatments and NT, but cannot, of course, replace a real
control group. However, there is a probability of a spon-
taneous effect of pain regression to the mean because the
pain level of our patients was severe. Therefore, it would
Table 7 Diagnostic groups versus change in pain after one year
Disorders of the spine and back Other disorders of the motor system Headaches Other pain Total
n % n % n % n % n %
Patients 155 (100) 41 (100) 34 (100) 50 (100) 280 (100)
Change in symptoms
Worsening 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.0) 1 (0.4)
No change 31 (20.0) 11 (26.8) 10 (29.4) 8 (16.0) 60 (21.4)
Slight improvement 32 (20.7) 5 (12.2) 5 (14.7) 10 (20.0) 52 (18.6)
Marked improvement 77 (49.7) 15 (36.6) 12 (35.3) 22 (44.0) 126 (45)
No pain 15 (9.7) 10 (24.4) 7 (20.6) 9 (18.0) 41 (14.6)
Table 9 Medication intake and change in symptoms
Treatment effecta
Medication intake No success Success
n %b n %b
No medication 18 (29.5) 69 (31.5)
No change in medication intake 40 (65.6) 10 (4.6)
Reduced use of (or no more need for)
medication
3 (4.9) 140 (63.9)
Increased use of medication 0 (0) 0 (0)
Total 61 (100) 219 (100)
a according to the patients’ self-assessment
b percentage within this category
Table 8 Treatment modality vs. change in pain after one year
Local/segmental Interference field Combined
n %a n %a n %a
Patients 157 (100) 5 (100) 118 (100)
Change in symptoms
Worsening 1 (0.6) 0 (0.0) 0 (0.0)
No change 34 (21.7) 0 (0.0) 26 (22.0)
Slight improvement 29 (18.5) 3 (60.0) 20 (17.0)
Marked improvement 65 (41.4) 1 (20.0) 60 (50.9)
No pain 28 (17.8) 1 (20.0) 12 (10.2)
a percentage of the respective treatment modality
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be expected that some patients by chance would find their
pain reduced over the study period. Without a control
group it is therefore difficult to assess what amount of
pain reduction is due to the treatment and what amount
due to the potential regression to the mean. Nevertheless,
it is fair to say that the mean duration of pain illness with-
out regression before NT was more than five years. After
this long period, a significant improvement without ther-
apy seems improbable.
Despite the severity of the pain disorder and the long
duration of illness prior to NT, patients only needed an
average of 9.2 consultations within a period of one year.
In the long term only one fifth of our patients
remained resistant to NT (as to conventional medical
treatment options before). Another fifth experienced a
slight improvement, and three fifths a marked improve-
ment of pain or even freedom of pain. These results are
supported by a Health Technology Assessment report
[4] and other studies [36–38]. Furthermore, NT, which
has been empirically developed in normal, everyday clin-
ical practice, is in line with modern knowledge of the
neurophysiology of pain and neurogenic inflammation
[7, 26, 29, 32, 34, 39–42].
Combined injections of local anesthetics (NT) primar-
ily affect the efferent and afferent fibers of the peripheral
spinal reflex arc, largely via the sympathetic nervous
system involved in the pain processes. Due to the con-
nection of the central reflex arcs in the brain stem and
in the cortex with neurons within the spinal cord it
seems likely that they are indirectly affected by NT. On
the other hand, these central reflex arcs are also subject
to other influences, such as emotions (for example, the
doctor-patient relation), especially in the presence of the
respective neuroplastic changes. For this very reason we
cannot determine the exact size of the specific effect of
NT with our present results. However, the majority of
our patients had received interventions within a similar
doctor-patient setting (physiotherapy, acupuncture, psy-
chotherapy, manual therapy, interventional pain man-
agement) prior to their enrollment in this case series,
and still had been unresponsive to treatment. This is
why we suppose that a part of the effect of NT may be
specific.
The second outcome measure was the consumption of
pain-relieving drugs: out of the 193 patients under pain
medication three quarters took less pain medication or
none at all after one year. These findings are noteworthy
for their cost-effectiveness implications. In our cross-
sectional studies [38, 43] commissioned by the Swiss
Federal Office of Public Health (BAG) we also noted bet-
ter cost-effectiveness implications in primary care pro-
viders who had incorporated NT in their practice
(compared to primary care providers offering conven-
tional medical treatment alone). The same results we
saw filing an application to the Swiss Federal Office of
Public Health [5]: we were able to compile the following
Fig. 1 Reflectory connections between skin, muscle and internal organ: a simplified schematic diagram. The arrows indicate possible sites of injection
with local anesthetics. The injections can be combined
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data from the Association of Swiss Health Insurance
Companies (SantéSuisse): primary care providers offering
integrative NT were compared to those providing conven-
tional medicine alone. Both total costs and medication
costs (average costs per year per patient) were significantly
lower in the NT group.
Limitations
Although the present case series was conducted under
circumstances similar to those found in daily practice
and its results can be transferred into the clinical and
practice setting, there are still limitations. As it was – in
this real-life setting with patients referred explicitly to
NT – not possible to opt for a controlled study design,
the exact size of the specific effect of NT cannot be
determined in this case series. Although the chance of a
significant spontaneous improvement without therapy in
our patients with refractory chronic pain over a long
period was little, this possibility cannot be ignored. Being
designed as a case series and not a multicenter trial
makes it difficult to generalize the findings. Moreover,
general quality of life and activities of daily living as well
as secondary diagnosis were recorded in the course of
history taking, but not included in the analysis of data.
Conclusions
Chronic pain, especially back pain, is extremely com-
mon. Treatment-resistant pain syndromes or adverse ef-
fects of medical treatment demand other treatment
options. Both the present results for the outcome mea-
sures pain and medication use are in line with the
results of other studies and demonstrate that therapeutic
local anesthesia (NT) is a good treatment option. This is
also reflected in the fact that many of the referring
physicians were pain specialists or specialists in muscu-
loskeletal disorders, and that every eighth referral was
made by university hospitals or their outpatient depart-
ments. The good long-term outcomes achieved in just a
few visits – such as medication reduction and virtually
no side effects – are interesting from an economic per-
spective as well. As discussed above and mentioned
under limitations, we cannot determine the exact size of
the specific effect of NT in this uncontrolled case series.
It would be, therefore, worthwhile to carry out a con-
trolled trial to evaluate the true effect of NT.
Nevertheless, the results of our study can be logically
explained by mechanisms of action that are based on
modern neurophysiological concepts of pain. In addition,
the fact that in most patients the effect persisted much
longer than was to be expected from the duration of
action of the local anesthetic also supports our initial
hypothesis that the injection of local anesthetics at suit-
able sites can disrupt the vicious circle of pain (multiple
reflex arcs maintaining each other through positive
feedback) and thus initiate a reorganization (self-
organization) of the pain-processing systems. The re-
sults of further research into the mechanisms of action
on the one hand and the outcome of future randomized
controlled trials on the other will be eagerly awaited.
Endnotes
1Categories 4–6 (1 = no pain, 2 = mild pain, 3 =moder-
ate pain, 4 = severe pain, 5 = very severe pain, 6 = unbear-
able pain)
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